Stocks and Investing Stocks and Investing
Tue, July 12, 2022
Mon, July 11, 2022
Sun, July 10, 2022
Fri, July 8, 2022

Robert Driscoll Initiated (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022


Published on 2024-10-27 21:48:43 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Initiated "Aprea Therapeutics, Inc." (APRE) at Buy and Held Target at $60 on, Jul 8th, 2022.

Robert has made no other calls on APRE in the last 4 months.



There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, all agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Fein of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $40 on, Wednesday, March 16th, 2022
  • Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $80 on, Wednesday, March 16th, 2022